AdvancedDx Biological Laboratories and Complete Genomics Form Partnership for NGS-Based Infectious Disease Assays
MOC Cancer Care & Research Centre Unveils CAR-T Cell Therapy
CJI Calls for Universal Access to Gene Therapy
Quad Cancer Moonshot: A United Effort to Eliminate Cervical Cancer in the Indo-Pacific
ICGA Launches India's First Open-Access Cancer Data Portal to Advance Personalized Treatment
Redcliffe Labs Introduces Gut Microbiome and HealthEx Tests to Enhance Preventive Healthcare
New Novartis Data Highlight Kesimpta® Benefits for First-Line and Switch Patients in Relapsing Multiple Sclerosis
IMAC Holdings Inc. Unveils Ignite Proteomics Subsidiary and Introduces Innovative Precision Oncology Case Study Featuring RPPA Technology
CS Genetics and ROSALIND® Join Forces to Expand Access to Single-Cell Genomics
Neuberg Diagnostics Unveils Geniee: A Personalized Genomics Platform
GE HealthCare's MIM Software Receives FDA Clearance for New Centiloid Scaling Tool to Quantify Amyloid Plaque in Brain Imaging
FDA Approves Merck's KEYTRUDA® (Pembrolizumab) in Combination with Pemetrexed and Platinum Chemotherapy as a First-Line Treatment for Adults with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)
OncoLens Introduces Real-Time Oncology Patient Identification for Clinical Trials and Essential Services
Biognosys and Thermo Fisher Sign Reselling Agreement for Spectronaut Proteomics Software
TVM Capital Healthcare Invests in Human Longevity Inc. to Drive Global Expansion of Precision Medicine